Polyisoprene-Silica Nanoparticles Synthesized via RAFT Emulsifier-Free Emulsion Polymerization Using Water-Soluble Initiators.

Polyisoprene-silica (PIP-co-RAFT-SiO2) nanoparticles were prepared via reversible addition⁻fragmentation chain-transfer (RAFT) emulsifier-free emulsion polymerization using water-soluble initiators, 4,4'-Azobis (4-cyanopentanoic acid) (ACP) and 2,2'-Azobis (2-methylpropionamidine) dihydrochloride (V50). The particle size of emulsion prepared using ACP initiator was smaller than that using V50 initiator because the V50 initiator was more active toward decomposition than the ACP initiator. A high monomer conversion (84%), grafting efficiency (83%) and small particle size (38 nm) with narrow size distribution were achieved at optimum condition. The PIP-co-RAFT-SiO2 nanoparticles exhibited core⁻shell morphology with silica encapsulated with polyisoprene (PIP). The new PIP-SiO2 nanoparticles could be applied as effective filler in rubber composites that possess good mechanical and thermal properties.

Preparation of pH-responsive polymer core-shell nanospheres for delivery of hydrophobic antineoplastic drug ellipticine.

Antineoplastic drug ellipticine and its derivatives are used in human cancer therapy. However, their clinical applications have been limited by its great hydrophobicity and severe side effects. An efficient delivery system is therefore very desirable. In this research, an ellipticine-loaded core-shell structured nanosphere namely poly(DEAEMA)-poly(PEGMA) is designed as a drug carrier and prepared via a two-step semibatch emulsion polymerization method where DEAEMA and PEGMA represent 2-(diethylamino)ethyl methacrylate and poly(ethylene glycol) methacrylate, respectively. The in-vitro release profiles of ellipticine towards the different pH liposome vesicles are recorded as a function of time at 37 °C. It is found that release of ellipticine from the core-shell polymer matrix is a pH-responsive and controlled release process. The three pH's of 3, 4, and 5 trigger a significant ellipticine release of 88% after 98 h, 83% after 98 h, and 79% after 122 h, respectively. The release mechanism of ellipticine from the core-shell polymer matrix under acidic conditions is explored. The synthesis and encapsulation process developed herein provides a new perspective for the development of appropriate delivery systems to deliver the ellipticine and its analogues, as well as other types of hydrophobic drugs to a given target cell or tumor tissue.

Bimetallic dendrimer-encapsulated nanoparticles as catalysts: a review of the research advances.

Bimetallic dendrimer-encapsulated nanoparticles (DENs) are important materials, because they have demonstrated improvement in performance compared to the monometallic DENs in many systems when they are used as catalysts. This tutorial review focuses on the recent research advances in bimetallic DENs with respect to their synthesis, characterization, and applications as catalysts. Bimetallic DENs can be made mainly via three routes: co-complexation, sequential loading, and partial displacement. The research in bimetallic DENs has been significantly promoted by the advancement of characterization instruments. The performances of bimetallic DENs as homogeneous and heterogeneous catalysts in organic synthesis have been compared with both monometallic DENs and their physical mixtures. It is concluded that the synergistic electronic effect in bimetallic nanoparticles enhances their catalytic activities.

Holographic coherence tomography for measurement of three-dimensional refractive-index space.

A new tomographic method for the measurement of three-dimensional refractive-index fields of transparent media, which we call holographic coherence tomography and which combines double-exposure holographic interferometry with the detecting style of optical coherence tomography, has been developed. The three-dimensional refractive-index field can be achieved with a confocal lens system by continual longitudinal and horizontal scanning of the holographic reconstruction image.